ALK announces new epinephrine auto-injector strategy based on innovative new product for the USA
ALK today announced that it has finalised its strategy for entering the US market for epinephrine (adrenaline) auto-injectors (EAIs) and that this will focus on a next-generation EAI in partnership with US-based Windgap Medical. Read more >>